In clinical trials, about 11%21% of people on Zepbound experienced constipation
Alvarez-Bagnarol Y, Marchette RC, Francis C, Morales M, Vendruscolo LF
It is an ongoing therapy, which makes long-term dosing efficiency and peptide cost calculations particularly relevant
We were executing plays that we had been practicing for the past couple weeks and they worked well, Legorreta said
Patients should also contact their provider promptly if they experience: Persistent or worsening nausea and vomiting lasting more than a few days Inability to maintain adequate oral intake of food or fluids Symptoms of hypoglycemia (shakiness, sweating, confusion, rapid heartbeat), particularly if taking tirzepatide with insulin or sulfonylureas Signs of allergic reaction, including rash, itching, swelling, or difficulty breathing Changes in vision or symptoms of diabetic retinopathy progression, especially with rapid improvement in blood glucose New lump or swelling in the neck, hoarseness, or difficulty swallowing (potential thyroid tumor symptoms) Routine follow-up should address less urgent concerns such as persistent mild nausea affecting quality of life, ongoing constipation or diarrhea, injection site reactions that don't resolve, or questions about dose adjustment
